Prostate cancer remains one of the most frequently diagnosed cancers among men worldwide and a leading cause of cancer-related deaths. While advances in surgery, radiation therapy, hormone treatments, and targeted drugs have improved outcomes for many patients, aggressive and treatment-resistant forms of the disease continue to present significant challenges.
